Stock Option

Ensol Biosciences Inc.

140610·KONEX·12 grants

Shares granted, cumulative
897,200shares
Next lockup release
D-218
2027-03-26

Against the share price

At the 2026-08-18 close
KRW
-2.97%
Shares with a reason to exercise
141,500 shares
0.98% of shares outstanding
Sellable right now
141,500 shares
100% of the shares with a reason to exercise
Unrealized paper gain (to the employees)
₩399.7M

Potential dilution

2.64%Against the 15% cap

Shares by strike price

  • ₩25,150123K shares
  • ₩16,70051K shares
  • ₩15,10025K shares
  • ₩14,8509K shares
  • ₩14,4003K shares
  • ₩13,85029K shares
  • ₩10,460Latest price
  • ₩7,850134K shares
  • ₩3,7958K shares

Below the line (strike < Latest price) sits above the strike price: 142K shares, 37% of the shares still inside their exercise window.

Options the share price has risen past gain a reason to be exercised and sold once the lockup ends. Filings do not show what has already been exercised or forfeited, so these figures are on a cumulative grants basis and the shares actually outstanding may be fewer.

Share price vs. strike price

A strike price is fixed on the grant date; only the share price moves. Where the price line crosses a dashed line is when that block of options first had a reason to be exercised.

Close ₩10,4602025-08-14 ~ 2026-08-18
  • Strike ₩7,850134K sharesabove
  • Strike ₩25,150123K shares
  • Strike ₩16,70051K shares
  • Strike ₩13,85029K shares

Recipients by role

897KShares granted
  • Unregistered officer12 people65%
  • Employee42 people22%
  • Other · unknown11 people13%

Sorted from the relation text written in the filings (65 recipients). Officers of affiliates and subsidiaries are counted as unregistered officers.

Shares granted by year

518K
163K
51K
27K
8K
123K
9K
'19
'20
'21
'22
'23
'24
'25
'26

Cumulative grants per recipient

31 named
Largest holder심 재학Unregistered officer
Top holder 21.1%Top 3 50.1%
RecipientShares, cumulativePaper gain
80,00021.1%₩208.8M
80,00021.1%—
30,0007.9%—
20,0005.3%₩52.2M
20,0005.3%₩52.2M
20,0005.3%—
18,0004.7%—
10,0002.6%—
10,0002.6%—
10,0002.6%—

Recipients granted less than 10 in 10,000 of total shares issued have their names withheld under the disclosure rules; they cannot be split apart, so they are grouped into one row. Rows that pack several people onto one line, such as “OOO and 6 others”, are grouped there too, with the headcount read from that text — the split between them is never disclosed, so “my share” can only be prefilled with the per-person average. Filings carry no employee number or year of birth, so people with the same name are added together as one. “Exercisable” counts shares whose lockup has already ended, and any paper gain accrues to the employees holding the options.

Every figure here is parsed mechanically from the original DART filing (document.xml). “Exercise starts (estimated)” means the filing did not state an exercise period, so the date is the grant date plus two years under Article 340-2(4) of the Korean Commercial Act and may differ from the actual terms. Always read the original filing before making any decision.